Global Deterioration Scale
Also known as: Reisberg GDS, GDS Staging Scale, Reisberg Stages, Seven-Stage Dementia Staging
The Global Deterioration Scale (GDS) is a seven-stage clinical staging instrument that locates an older adult along the continuum of cognitive decline, from no impairment through very severe dementia. Introduced by Barry Reisberg and colleagues in 1982, it was designed to give clinicians and researchers a shared, ordinally graded vocabulary for the natural history of primary degenerative dementia, most prominently Alzheimer's disease. Rather than producing a numeric test score, the GDS asks the assessor to match a patient's cognitive, functional, and behavioral picture — gathered through clinical interview and informant report — to one of seven prototypical stage descriptions. Stages 1 to 3 cover the spectrum from normal cognition through subjective and then mild objective decline, stage 4 marks the threshold of clinically diagnosable dementia, and stages 5 to 7 trace the progression through moderate, moderately severe, and severe disease toward total dependence. Because the stages are ordered and clinically anchored, the GDS supports tracking decline over time, communicating prognosis, and stratifying patients in trials and care planning. It remains one of the most widely used global staging tools in gerontology and is often paired with the companion FAST and BCRS instruments from the same group.
Key highlights
- Provides a single, ordinally ordered global summary of dementia severity that is easy to communicate and compare across patients and time.
- Spans the full continuum from normal cognition through very severe dementia, capturing pre-dementia stages that purely diagnostic instruments ignore.
- Integrates cognitive, functional, and behavioral evidence rather than relying on test performance alone, which matters as function dominates later stages.
- Is widely adopted and pairs with the companion FAST and BCRS scales, giving it broad comparability and a large validation literature.
Intuition
This section is available to Pro members. Upgrade to Pro
How it works
This section is available to Pro members. Upgrade to Pro
When to use it
Use the Global Deterioration Scale when you need a concise, ordinally graded summary of overall dementia severity in an older adult and you can draw on both clinical examination and informant report covering everyday function. It is well suited to memory clinics, longitudinal cohorts, and trials that require stratifying participants by severity or documenting progression over time, and to care settings where a shared staging vocabulary aids communication and planning. It is less appropriate as a stand-alone case-finding or screening tool, where a structured cognitive test is preferable, and it depends on a knowledgeable informant, so it is weaker when functional history is unavailable. The GDS is also primarily validated for Alzheimer-type primary degenerative dementia and maps less cleanly onto conditions with atypical, non-amnestic, or fluctuating courses, where its assumption of orderly global decline can mislead.
Strengths & limitations
- Provides a single, ordinally ordered global summary of dementia severity that is easy to communicate and compare across patients and time.
- Spans the full continuum from normal cognition through very severe dementia, capturing pre-dementia stages that purely diagnostic instruments ignore.
- Integrates cognitive, functional, and behavioral evidence rather than relying on test performance alone, which matters as function dominates later stages.
- Is widely adopted and pairs with the companion FAST and BCRS scales, giving it broad comparability and a large validation literature.
- Stage assignment is a clinical, judgment-based match to prototypes, so it is more subjective and rater-dependent than a scored test.
- It assumes a broadly orderly, monotonic global decline and fits Alzheimer-type dementia better than atypical or fluctuating presentations.
- It requires a reliable informant and functional history, limiting use where only the patient is available.
- As an ordinal scale of seven coarse categories it is relatively insensitive to small changes and should not be treated as an interval measurement.
Common pitfalls
This section is available to Pro members. Upgrade to Pro
Applications
This section is available to Pro members. Upgrade to Pro
Frequently asked
Is the Global Deterioration Scale a cognitive test or a staging instrument?
It is a staging instrument, not a scored cognitive test. Instead of administering items and summing points, the clinician forms a global judgment from clinical interview and informant report and matches the patient to one of seven ordered stage descriptions. The result is an ordinal position on the course of dementia rather than a numeric performance score. For this reason the GDS complements, rather than replaces, structured cognitive screens, and it is often used together with one.
At which GDS stage does dementia become diagnosable?
Stage 4 is the conventional threshold. Stages 1 to 3 span normal cognition, very mild (often subjective) decline, and mild decline with the earliest objective deficits, none of which meets the bar for dementia. At stage 4 the deficits are clear enough to interfere with everyday activities and to support a clinical diagnosis of dementia, and stages 5 through 7 then track moderately severe, severe, and very severe disease. Recognizing that the lower stages are pre-dementia is important to avoid over-diagnosis.
How does the GDS relate to the FAST and BCRS scales?
All three come from Reisberg's group and were designed to work together. The GDS provides the overarching seven-stage global picture, the Brief Cognitive Rating Scale rates specific cognitive axes, and the Functional Assessment Staging Tool subdivides the more severe stages by concrete functional milestones such as dressing, continence, and speech. In advanced dementia, where cognitive testing is no longer feasible, clinicians often rely on FAST sub-stages to grade severity, while the GDS remains the common reference frame across the whole course.
Sources
- 1.Reisberg, B., Ferris, S. H., de Leon, M. J., & Crook, T. (1982). The Global Deterioration Scale for assessment of primary degenerative dementia. American Journal of Psychiatry, 139(9), 1136-1139.
You have read it. What now?
Cite this page
ScholarGate. (2026, June 23). Global Deterioration Scale. ScholarGate. https://scholargate.app/social-gerontology/global-deterioration-scale